Delta Lloyd’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$18.2M Buy
257,573
+1,602
+0.6% +$107K 0.51% 55
2017
Q1
$17.4M Buy
255,971
+3,387
+1% +$238K 0.52% 50
2016
Q4
$18.1M Buy
252,584
+17,781
+8% +$1.32M 0.57% 46
2016
Q3
$18.6M Buy
234,803
+12,603
+6% +$1.02M 0.58% 47
2016
Q2
$18.5M Sell
222,200
-10,478
-5% -$930K 0.62% 41
2016
Q1
$21.4M Sell
232,678
-30,964
-12% -$2.79M 0.71% 35
2015
Q4
$26.7M Buy
263,642
+4,747
+2% +$494K 0.92% 27
2015
Q3
$25.4M Buy
258,895
+68,128
+36% +$7.57M 0.81% 28
2015
Q2
$22.3M Buy
190,767
+124,247
+187% +$13.6M 0.7% 38
2015
Q1
$6.53M Sell
66,520
-1,722
-3% -$175K 0.2% 95
2014
Q4
$6.43M Buy
68,242
+3,365
+5% +$348K 0.19% 97
2014
Q3
$6.91M Buy
64,877
+3,457
+6% +$339K 0.06% 101
2014
Q2
$5.09M Buy
61,420
+6,070
+11% +$472K 0.16% 100
2014
Q1
$3.92M Sell
55,350
-91,001
-62% -$7.14M 0.13% 100
2013
Q4
$11M Sell
146,351
-69,083
-32% -$4.81M 0.38% 49
2013
Q3
$13.5M Buy
215,434
+153,446
+248% +$9.17M 0.52% 42
2013
Q2
$3.18M Buy
+61,988
New +$3.23M 0.12% 133

Other funds holding GILD

Delta Lloyd's GILD Position: Q2 2017 in Review

Delta Lloyd increased its Gilead Sciences (GILD) stake by 0.63% in Q2 2017, buying an estimated $107K and bringing the position to 257,573 shares worth $18.2M. The position accounts for 0.51% of the portfolio, ranked #55.

Delta Lloyd first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $26.7M in Q4 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Delta Lloyd held 257,573 shares of Gilead Sciences worth $18.2M as of Q2 2017.
  • Delta Lloyd bought 1,602 Gilead Sciences shares in Q2 2017, an estimated $107K.
  • Gilead Sciences made up 0.51% of Delta Lloyd's portfolio in Q2 2017, its #55 holding.
  • Delta Lloyd first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Gilead Sciences position peaked at $26.7M in Q4 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.